Understanding Immunity to the COVID-19 Vaccines

Official Title

Brief Summary

The purpose of this study is to test over time immunity to the COVID-19 vaccines. Adults who are receiving COVID-19 vaccines will be invited to participate.

Status

Completed

Conditions

COVID-19

Immunity

Vaccine

Interventions

Other: No intervention

No intervention

Eligibility Criteria

Inclusion Criteria:

- Adults who are receiving a COVID-19 vaccine

Exclusion Criteria:

- Patients with special risks attendant to venipuncture

Eligibility Gender

All

Eligibility Age

Minimum: 18 Years ~ Maximum: N/A

Countries

United States

Locations

Stanford University, Hospital, and Clinics
Stanford, California, United States

Investigators

Kari Nadeau, MD, PhD, Principal Investigator
Stanford University

NCT Number

NCT04664309

MeSH Terms

COVID-19

Disclaimer:

Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.

(202) 849 - 2075

1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036

admin@reaganudall.org

National Institutes of Health (NIH)

Understanding Immunity to the COVID-19 Vaccines

Disclaimer:

Subscribe for updates from the Reagan-Udall Foundation for the FDA